Stéphanie De Simoni

Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+

Stéphanie De Simoni, Julie Goemaere, Bernard Knoops · Neuroscience Letters · 2008 · 91 citations

Peroxiredoxin 3, Mitophagy, Molecular Neuroscience +10

Mitochondrial peroxiredoxin‐5 as potential modulator of mitochondria‐<scp>ER</scp> crosstalk in <scp>MPP</scp>⁺‐induced cell death

Stéphanie De Simoni, Dominique Linard, Emmanuel Hermans et al. · Journal of Neurochemistry · 2012 · 56 citations · Full text

Mitochondrial Dysfunction, Apoptosis, Cell Death +20

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial

Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim et al. · Human Vaccines & Immunotherapeutics · 2015 · 49 citations · Full text

Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years

Thanyawee Puthanakit, Li‐Min Huang, Cheng‐Hsun Chiu et al. · The Journal of Infectious Diseases · 2016 · 46 citations · Full text

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial

Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim et al. · Vaccine · 2017 · 27 citations · Full text